Bulletin

Pharma groups to pay NHS £550m 'rebate'

NHS benefit from rebate

The National Health Service is to receive a £550m 'rebate' from the pharmaceuticals industry next year as part of a deal that drugmakers hope will spur faster adoption of new medicines in Britain. Pharma companies will pay the sum under an agreement that caps growth in the NHS budget for branded drugs, with the industry reimbursing any spending that overruns the cap. Almost £1bn has been paid since the deal was struck in 2013; this week pharma companies reached an agreement with the Department of Health to pay £550m in 2016. The sum includes £200m brought forward from the estimated rebates that would have been due in 2017 and 2018. The Association of the British Pharmaceutical Industry said it hoped the upfront payment would help overcome hurdles to the adoption of new medicines.

 

Note: News bulletin content has been provided by a third-party and is not the opinion of Santander

Other Articles

This International Women’s Day, our analysis reveals a continuing untapped potential and huge opportunity when it comes to women in…

London

London-based ACT Clean has secured private investor backing for a £10.2 million management buyout.

Bulletin
Spain

Santander takes 12 UK food and drink manufacturers to Spain on one of our successful trade missions. Adam Payne in the international team…

This International Women’s Day, our analysis reveals a continuing untapped potential and huge opportunity when it comes to women in…

London

London-based ACT Clean has secured private investor backing for a £10.2 million management buyout.

Bulletin
Getting a taste for Spain!

Santander takes 12 UK food and drink manufacturers to Spain on one of our Trade Missions. Alicia Ferrero Vega in the International team…

Bulletin

Where Next?